NeuroNova AB
Laboratoire
📍 33 stockholm, 114
NeuroNova is develops drug targets and candidates that demonstrate potential in the treatment of neurodegenerative diseases. Its products include sNN0029, a drug candidate for the treatment of amyotrophic lateral sclerosis; and sNN0031, a drug candidate for the treatment of moderate to severe stage Parkinson’s disease that is designed to act on neural stem and progenitor cells in the brain.
À propos
Localisation: 33 stockholm, 114
🔒 Coordonnées (Abonnement payant requis)
Pour accéder aux coordonnées complètes (adresse, téléphone, email) et aux contacts de ce prestataire, passez à un compte payant.
Actions
Informations
Catégorie:
Laboratoire